HKU on Coronavirus (Aug 25-Sep 14)


HKU in the news (Aug 25-Sep 14)

Sep 14 HKU Chief of Infectious disease warns it may take another four to six weeks before Hong Kong sees zero daily infections again (Professor Ivan Hung) (link)

Sep 11 HKU microbiologist Professor Yuen Kwok-yung reveals the University will recruit 100 residents who are healthy for the first phase of three phases of clinical trials for the nasal spray vaccine developed by HKU starting November (link)

Sep 10 HKU State Key Laboratory for Emerging Infectious Diseases partnered with Xiamen University and Wantai Biopharmaceutical Company to rapidly develop a nasal spray vaccine candidate against COVID-19, with clinical trial in humans approved (link)

Sep 7 HKU Covid-19 vaccine, RBD replicating influenza vector, is shortlisted as the final 9 vaccines in the COVAX organized by WHO (link)

Sep 4 HKU Dean of Medicine estimates 400 infectious invisible Covid-19 carriers, calling for the government to procure vaccines (Professor Gabriel Leung) (link)

Sep 1 HKU Dean of Medicine takes part on the first day of government’s Universal Community Testing Programme (UCTP) and comments that it helps finding out hidden spreaders while the current reproductive rate is below 0.5 (Professor Gabriel Leung) (link)

Aug 29 HKU microbiologist Professor Yuen kwok-yung warns infections could spike again as temperatures fall, also calls for ‘watertight’ border controls, and for people to record their own movements to facilitate contact tracing in the event of infection (Professor Yuen Kwok-yun) (link)

Aug 27 HKUMed research led by microbiologist Professor Yuen kwok-yung discovers “P9R”, a new kind of broad-spectrum antiviral peptide, can inhibit six types of respiratory viruses, including COVID-19 and the flu (Professor Yuen Kwok-yun) (link)